Skip to content

Prime Medicine PRME Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$198.37M+1.8%-$201.14M-2.7%-$197.34M+10.0%-$199.28M+8.4%-$202.01M+1.2%
$7.48M+14.8%$7.32M+19.5%$7.16M+26.6%$6.84M+28.2%$6.51M+32.5%
$28.23M+6.4%$29.27M+12.3%$30.69M+25.0%$24.77M+12.9%$26.54M+52.2%
-$156.42M-$162.56M
$2.32M-68.6%$4.53M-37.9%$6.03M-17.9%$7.06M-21.3%$7.39M-18.3%
$57.75M+1,121%
$145.91M+228%$151.51M-22.6%$150.95M-23.0%$44.71M-71.7%$44.55M-71.8%
-$1.6M
-$158.74M-$167.1M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Prime Medicine generate?
Prime Medicine (PRME) generated -$156.4M in operating cash flow over the trailing twelve months.
What is Prime Medicine's free cash flow?
After $2.3M of capital expenditures, Prime Medicine's free cash flow was -$158.7M over the trailing twelve months, up 19.0% year over year.
Where does Prime Medicine's cash flow data come from?
Every line is extracted from Prime Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.